AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not α-sarcoglycan deficiency

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Gene Therapy

• Publication date

  2007-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.gt.3302928PMID 17330087
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phenotypic correction of alpha-sarcoglycan deficiency by intra-arterial injection of a muscle-specific serotype 1 rAAV vector.

  2007cited by this paper
• Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway.

  2007cited by this paper
• Noninvasive monitoring of therapeutic gene transfer in animal models of muscular dystrophies

  2006cited by this paper
• A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep

  2006cited by this paper
• Calpain 3: a key regulator of the sarcomere?

  2006cited by this paper
• Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A.

  2006cited by this paper
• Molecular and cell biology of the sarcoglycan complex

  2005cited by this paper
• Adeno-Associated Virus Pseudotype 5 Vector Improves Gene Transfer in Arthritic Joints

  2005cited by this paper
• Femoral intra‐arterial injection: a tool to deliver and assess recombinant AAV constructs in rodents whole hind limb

  2005cited by this paper
• Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway.

  2005cited by this paper
• Myostatin, a negative regulator of muscle mass: implications for muscle degenerative diseases.

  2005cited by this paper
• Myostatin: a modulator of skeletal-muscle stem cells.

  2005cited by this paper
• Molecular Pathogenesis of Genetic and Inherited Diseases Elimination of Myostatin Does Not Combat Muscular Dystrophy in dy Mice but Increases Postnatal Lethality

  2005cited by this paper
• The function of Myostatin and strategies of Myostatin blockade-new hope for therapies aimed at promoting growth of skeletal muscle.

  2005cited by this paper
• Myostatin: a therapeutic target for skeletal muscle wasting

  2004cited by this paper
• Myostatin mutation associated with gross muscle hypertrophy in a child.

  2004cited by this paper
• Regulation of muscle mass by myostatin.

  2004cited by this paper
• Myostatin mutation associated with gross muscle hypertrophy in a child.

  2004cited by this paper
• Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism.

  2004cited by this paper
• Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in vivo and in vitro.

  2004cited by this paper
• Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin.

  2003cited by this paper
• Myostatin Signals through a Transforming Growth Factor β-Like Signaling Pathway To Block Adipogenesis

  2003cited by this paper
• Myostatin-deficient mice lose more skeletal muscle mass than wild-type controls during hindlimb suspension.

  2003cited by this paper
• Modulating skeletal muscle mass by postnatal, muscle‐specific inactivation of the myostatin gene

  2003cited by this paper
• Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases

  2003cited by this paper
• Pharmacological strategies for muscular dystrophy

  2003cited by this paper
• The new frontier in muscular dystrophy research: booster genes

  2003cited by this paper
• Inhibition of myostatin in adult mice increases skeletal muscle mass and strength.

  2003cited by this paper
• Force impairment in calpain 3–deficient mice is not correlated with mechanical disruption

  2003cited by this paper
• Loss of myostatin attenuates severity of muscular dystrophy in mdx mice

  2002cited by this paper
• Functional improvement of dystrophic muscle by myostatin blockade

  2002cited by this paper
• A missense mutant myostatin causes hyperplasia without hypertrophy in the mouse muscle.

  2002cited by this paper
• Induction of Cachexia in Mice by Systemically Administered Myostatin

  2002cited by this paper
• The Myostatin Propeptide and the Follistatin-related Gene Are Inhibitory Binding Proteins of Myostatin in Normal Serum*

  2002cited by this paper
• Expression of myostatin pro domain results in muscular transgenic mice

  2001cited by this paper
• MUSEAP, a novel reporter gene for the study of long-term gene expression in immunocompetent mice.

  2001cited by this paper
• Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus

  2001cited by this paper
• Dominant negative myostatin produces hypertrophy without hyperplasia in muscle

  2000cited by this paper
• Progressive Muscular Dystrophy in α-Sarcoglycan–deficient Mice

  1998cited by this paper
• The sarcoglycan complex in limb-girdle muscular dystrophy.

  1998cited by this paper
• A deletion in the myostatin gene causes the compact (Cmpt) hypermuscular mutation in mice

  1998cited by this paper
• Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors

  1997cited by this paper
• Double muscling in cattle due to mutations in the myostatin gene.

  1997cited by this paper
• Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member

  1997cited by this paper
• Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle.

  1997cited by this paper
• A deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle

  1997cited by this paper
• Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A.

  1995cited by this paper
• Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy.

  1994cited by this paper
• Effects of stress on cattle with hereditary muscular hypertrophy.

  1973cited by this paper
• [Progressive muscular dystrophy].

  1965cited by this paper
• The FASEB Journal • Research Communication Myostatin propeptide-mediated amelioration of dystrophic pathophysiology

  year unknowncited by this paper

• ACE-031, a soluble activin type IIB receptor, increases muscle mass and strength in the common marmoset (Callithrix jacchus)

  2026cites this paper
• ACE-031, a Soluble Activin Type IIB Receptor, Increases Muscle Mass and Strength in the Common Marmoset (Callithrix jacchus)

  2025cites this paper
• Calpainopathy (limb-girdle muscular dystrophy type R1): clinical features, diagnostic approaches, and biotechnological treatment methods

  2025cites this paper
• Impact of Disease Severity and Disease-Modifying Therapies on Myostatin Levels in SMA Patients

  2024cites this paper
• The therapeutic potential of soluble activin type IIB receptor treatment in a limb girdle muscular dystrophy type 2D mouse model.

  2022cites this paper
• Antimyostatin Treatment in Health and Disease: The Story of Great Expectations and Limited Success

  2021cites this paper
• Current and Future Therapeutic Strategies for Limb Girdle Muscular Dystrophy Type R1: Clinical and Experimental Approaches

  2021influential citation
• Effects of exosome-mediated delivery of myostatin propeptide on functional recovery of mdx mice.

  2020cites this paper
• Muscle Atrophy

  2020cites this paper
• The elusive promise of myostatin inhibition for muscular dystrophy

  2020cites this paper
• Plasmid-Mediated Gene Therapy in Mouse Models of Limb Girdle Muscular Dystrophy

  2019cites this paper
• Calcium Mechanisms in Limb-Girdle Muscular Dystrophy with CAPN3 Mutations

  2019cites this paper
• Past, Present, and Future Perspective of Targeting Myostatin and Related Signaling Pathways to Counteract Muscle Atrophy.

  2018cites this paper
• Emerging therapeutic strategies for sarcoglycanopathy

  2017cites this paper
• Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches

  2017cites this paper
• Adeno-associated virus-mediated expression of myostatin propeptide improves the growth of skeletal muscle and attenuates hyperglycemia in db/db mice

  2016cites this paper
• Calpain research for drug discovery: challenges and potential

  2016cites this paper
• The Pathogenesis and Therapy of Muscular Dystrophies.

  2015cites this paper
• Prospect for Pharmacological Therapies to Treat Skeletal Muscle Dysfunction

  2015cites this paper
• Inhibition of activin A ameliorates skeletal muscle injury and rescues contractile properties by inducing efficient remodeling in female mice.

  2014cites this paper
• Large Yellow Croaker MSTN-1 Prodomain Prokaryotic Expression, Polyclonal Antibody Preparation and Antibody Function Identification

  2014cites this paper
• Advances in gene therapies for limb-girdle muscular dystrophies

  2014influential citation
• Geneand cell-based therapy of muscle system hereditary disorders: state-of-art

  2014cites this paper
• Ongoing Developments in Sporadic Inclusion Body Myositis

  2014cites this paper
• Limb-girdle muscular dystrophies: Where next after six decades from the first proposal (Review)

  2014cites this paper
• The Effect of Myostatin on Glucose Metabolism and Insulin Sensitivity

  2013cites this paper
• The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy.

  2013cites this paper
• Gene doping: an overview and current implications for athletes

  2013cites this paper
• Animal models for metabolic, neuromuscular and ophthalmological rare diseases

  2013cites this paper
• Cell–matrix interactions in muscle disease

  2012cites this paper
• Inhibiting myostatin reverses muscle fibrosis through apoptosis

  2012cites this paper
• myo-Identification of Differentially Expressed Genes in Improved Rainbow Trout Growth by Treatment with a Fish Myostatin Prodomain Using the Annealing Control Primer System

  2012cites this paper
• Inhibition of myostatin reverses muscle fibrosis through apoptosis

  2012cites this paper
• Production of Bioactive Rockfish (Sebastes schlegeli) Myostatin-1 Prodomain in an Escherichia coli System

  2011cites this paper
• Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease

  2011cites this paper
• Role of TGF-β signaling in inherited and acquired myopathies

  2011cites this paper
• Long-Term Systemic Myostatin Inhibition via Liver-Targeted Gene Transfer in Golden Retriever Muscular Dystrophy

  2011cites this paper
• Role of Myostatin in Skeletal Muscle Growth and Development: Implications for Sarcopenia

  2011cites this paper
• Targeting the activin type IIB receptor to improve muscle mass and function in the mdx mouse model of Duchenne muscular dystrophy.

  2011cites this paper
• Limb-girdle muscular dystrophy 2A.

  2011cites this paper
• Systemic gene delivery for muscle gene therapy

  2010cites this paper
• Combination of myostatin pathway interference and dystrophin rescue enhances tetanic and specific force in dystrophic mdx mice.

  2010cites this paper
• The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B)

  2010cites this paper
• Extracellular Regulation of Myostatin: A Molecular Rheostat for Muscle Mass.

  2010cites this paper
• Nouveaux outils exploratoires et développement d'approches thérapeutiques dans les dysferlinopathies primaires

  2010influential citation
• Functional assessment of skeletal muscle in intact mice lacking myostatin by concurrent NMR imaging and spectroscopy

  2010cites this paper
• METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11.

  2010cites this paper
• Systemic Myostatin Inhibition via Liver-Targeted Gene Transfer in Normal and Dystrophic Mice

  2010cites this paper
• Improving rainbow trout (Oncorhynchus mykiss) growth by treatment with a fish (Paralichthys olivaceus) myostatin prodomain expressed in soluble forms in E. coli

  2010cites this paper
• Combinatorial Gene Therapy Strategies for Treating Muscular Dystrophies

  2010cites this paper
• Novel therapeutic approaches for inclusion body myositis

  2010cites this paper
• AAV-directed muscular dystrophy gene therapy

  2010cites this paper
• Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice.

  2009cites this paper
• Therapy for neuromuscular disorders.

  2009cites this paper
• Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy.

  2009cites this paper
• Hydrodynamic Limb Vein Injection of Adeno-Associated Virus Serotype 8 Vector Carrying Canine Myostatin Propeptide Gene into Normal Dogs Enhances Muscle Growth

  2009cites this paper
• Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects

  2009cites this paper
• Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease

  2009cites this paper
• Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice.

  2009cites this paper
• Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity

  2009cites this paper
• Relation between extent of myostatin depletion and muscle growth in mature mice.

  2009cites this paper
• Adeno-Associated Virus-8-Mediated Intravenous Transfer of Myostatin Propeptide Leads to Systemic Functional Improvements of Slow but Not Fast Muscle

  2009cites this paper
• Molecular, cellular and physiological investigation of myostatin propeptide-mediated muscle growth in adult mice.

  2009cites this paper
• The hunt for gene dopers.

  2009cites this paper
• Gene therapy for muscular dystrophy: current progress and future prospects

  2009cites this paper
• Follistatin gene therapy for the treatment of muscular dystrophy.

  2009cites this paper
• Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle.

  2009cites this paper
• Hydrodynamic limb vein injection of AAV8 canine myostatin propeptide gene in normal dogs enhances muscle growth

  2008cites this paper
• Efficient gene transfer in skeletal muscle with AAV-derived bicistronic vector using the FGF-1 IRES

  2008cites this paper
• Targeting myostatin for therapies against muscle-wasting disorders.

  2008cites this paper
• Myostatin as a therapeutic target for musculoskeletal disease

  2008cites this paper
• Myostatin Propeptide Gene Delivery by Adeno-Associated Virus Serotype 8 Vectors Enhances Muscle Growth and Ameliorates Dystrophic Phenotypes in mdx Mice

  2008cites this paper
• Heterogeneous pathogenesis of LGMD 2 : consequences for therapy

  2008cites this paper
• Myostatin is a procachectic growth factor during postnatal myogenesis

  2008cites this paper
• EVIEW Signal Transduction Pathway through Activin Receptors as a Therapeutic Target of Musculoskeletal Diseases and Cancer

  2008influential citation
• Nouvelles stratégies thérapeutiques des dystrophies musculaires

  2008cites this paper
• Therapeutic possibilities in the autosomal recessive limb-girdle muscular dystrophies

  2008cites this paper
• Caveolin-3 regulates myostatin signaling. Mini-review.

  2008cites this paper
• Myostatin inhibition by a follistatin-derived peptide ameliorates the pathophysiology of muscular dystrophy model mice.

  2008cites this paper
• Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer.

  2008cites this paper
• Progress and prospects: gene therapy for performance and appearance enhancement

  2008cites this paper
• Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice

  2008cites this paper
• Ins and outs of therapy in limb girdle muscular dystrophies.

  2007cites this paper
• Myostatin in the Pathophysiology of Skeletal Muscle

  2007cites this paper
• Potential use of gene transfer in athletic performance enhancement.

  2007cites this paper